Exit

 

With the final approval of the EFPIA Disclosure Code at the end of June and the implementation of the US Sunshine Act starting in August, transparency requirements and public disclosure become a reality for pharmaceutical companies.

To view the full article:

Bouton cliquez ici

Close
Go top